about
No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohortDisease-associated XMRV sequences are consistent with laboratory contaminationAnalysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infectionHepatitis C virus: evidence for sexual transmissionChronic liver disease due to hepatitis CWhole Blood as an Alternative to Plasma for Detection of Hepatitis C Virus RNAThe MIQE guidelines: minimum information for publication of quantitative real-time PCR experimentsQuantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples.Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon.Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate a mature phenotype.Carcinomatous meningitis diagnosed with monoclonal antibodies.Evaluation of an ethidium monoazide-enhanced 16S rDNA real-time polymerase chain reaction assay for bacterial screening of platelet concentrates and comparison with automated cultureDiagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencingAn international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.Detection of Rare Drug Resistance Mutations by Digital PCR in a Human Influenza A Virus Model System and Clinical Samples.Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.Instability of 8E5 calibration standard revealed by digital PCR risks inaccurate quantification of HIV DNA in clinical samples by qPCR.Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products.The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments.Comparative study of sensitivity, linearity, and resistance to inhibition of digital and nondigital polymerase chain reaction and loop mediated isothermal amplification assays for quantification of human cytomegalovirus.Polymerase chain reaction and transfusion microbiology.Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS.Hepatitis C viraemia in adults with type 2 autoimmune hepatitis.Virological, biochemical and histological effects of human lymphoblastoid interferon in Swedish patients with chronic hepatitis C.Improvement of HCV genome detection with "short" PCR products.Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.Hepatitis C virus infection in haemodialysis patients: a clinical and virological study.Transmission of hepatitis C virus by organ transplantation in the United Kingdom.Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients.Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma.Immunohistological diagnosis of primary brain lymphoma using monoclonal antibodies: confirmation of B-cell origin.Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis.The need for transparency and good practices in the qPCR literature.Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species.Development of a pan-retrovirus detection system for multiple sclerosis studies.
P50
Q21560843-7C671C39-DC86-4AF1-A8B0-ACE7E9A9BA34Q24602555-11E45469-E16D-4435-A878-E4D37F339BA0Q24606155-60B27B3C-ACE0-4D75-B346-6994C706AB7AQ27477698-9ABCEB4F-F075-48CD-A06A-216225E0609BQ27477722-FCE680E8-49A1-4B84-9610-2A3768D69224Q27487307-96138557-11A2-4BC0-8303-2A1E92118B5CQ28236560-E61902DC-6F36-47F9-9E04-896D66D7A8A4Q33335534-F98F4F55-9805-4A9C-9BFC-51596A343C9AQ33364562-A22AA334-D5AF-49EF-B23D-B35E75CA2919Q33838760-249F52B1-CCBE-450C-83F9-B202311A0965Q34548292-9BE7F6F3-4E66-4173-B351-86BCEFF4A21EQ34805484-F122EF83-941C-4B50-B047-CEF808921E03Q35135482-6843B24C-AA3C-4D3A-B192-E592C72114BEQ35273824-A2EC4E68-E9E9-4863-97AB-CAE737238AC8Q36521356-E47CB864-BD1C-41AA-BE88-45481432AF96Q36747463-F99714D9-96F4-4AD0-A191-2DC5683766ADQ38291515-9E7311E2-955C-44AF-AF20-E56DE75216ACQ38705900-89967106-A6FE-4C57-A8FE-235EFA6C9208Q39537084-C32C7932-753B-4691-A834-4E64BFD86548Q40103939-F3F5254F-5DE4-40FC-9428-FA100674239AQ40181094-1BE82722-D000-485E-8A6C-C8F6AB1A3487Q40852429-079D660A-7EE0-4C8D-AF87-13DCCC89F656Q41139549-51D12794-277A-462D-868F-3C5BADBB3F05Q42984818-42ECEFCE-1FBF-4274-ACE2-182923D1009CQ42984838-652C1609-94E6-4E83-978D-6631C44123D8Q42985526-B5161F0D-796D-4F34-98F0-7FCA7F231EE0Q42985871-3374D017-DFE2-4DE7-8C13-C5A9646A163DQ42993645-C213A227-791D-4A40-8FD7-652876AD2D63Q43036080-FD29D0DF-37BB-4CEE-9635-D2766AC15D87Q43036166-21A26224-551C-4C51-A5BD-208F9AF3C161Q43036210-DEA44B28-B837-4EAD-9228-B0F7773E3F9CQ43048321-10A2DD58-2881-4CE3-A490-2C4F2F4B64D8Q43481839-3AA47F75-5C4C-46E0-90D7-672B515E0DE9Q44753054-E3587AD9-5B79-4E63-9768-08373AD15308Q44854514-F853C517-16CD-4EA4-A014-78CB7F831529Q45722151-0C943F46-3167-4A85-8EF9-D979935BCA01Q45735981-2348F6FF-E82C-4CF2-B7BE-83C41DC7670AQ45903314-7DBA7BFD-7EC8-447F-A3B8-FB1F6A02A7C5Q46445484-D2F94FC6-ED1D-4B2C-A551-EB9DB8137965Q48055710-D4DDB3F7-69BD-453F-84F2-1EE8E4463528
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeremy A Garson
@ast
Jeremy A Garson
@en
Jeremy A Garson
@es
Jeremy A Garson
@nl
type
label
Jeremy A Garson
@ast
Jeremy A Garson
@en
Jeremy A Garson
@es
Jeremy A Garson
@nl
prefLabel
Jeremy A Garson
@ast
Jeremy A Garson
@en
Jeremy A Garson
@es
Jeremy A Garson
@nl
P106
P31
P496
0000-0003-0553-0126